Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Therapy for Synchronous Colorectal Liver Metastases
NCT00659022Phase 2Unknown
- Sponsor
- Radboud University Medical Center
- Start
- Jul 2008
- Primary completion
- Mar 2014
- Modality
- Monoclonal Antibodies, DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab, capecitabine, oxaliplatin in colorectal cancer (CRC), liver metastases, sponsored by Radboud University Medical Center. Status: unknown.
02
Drugs
bevacizumabcapecitabineoxaliplatin
03
Conditions
colorectal cancer (CRC)liver metastases
Beyond the preview
Go deeper on NCT00659022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00659022.